Prognostic Utility of Pericardial Effusion in the General Population: Findings From the STAAB Cohort Study
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.124.035549 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Floran Sahiti und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research and Epidemiology, Comprehensive Heart Failure Center University Hospital and University of Wurzburg Germany. Hauptthemen laut MEDLINE: Pericardial Effusion, Incidental Findings, Echocardiography, Peptide Fragments. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The incidental finding of a pericardial effusion (PE) poses a challenge in clinical care. PE is associated with malignant conditions or severe cardiac disease but may also be observed in healthy individuals. This study explored the prevalence, determinants, course, and prognostic relevance of PE in a population‐based cohort. Methods and Results The STAAB (Characteristics and Course of Heart Failure Stages A/B and Determinants of Progression) cohort study recruited a representative sample of the population of Würzburg, aged 30 to 79 years. Participants underwent quality‐controlled transthoracic echocardiography including the dedicated evaluation of the pericardial space. Of 4965 individuals included at baseline (mean age, 55±12 years; 52% women), 134 (2.7%) exhibited an incidentally diagnosed PE (median diameter, 2.7 mm; quartiles, 2.0–4.1 mm). In multivariable logistic regression, lower body mass index and higher NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) levels were associated with PE at baseline, whereas inflammation, malignancy, and rheumatoid disease were not. Among the 3901 participants attending the follow‐up examination after a median time of 34 (30–41) months, PE was found in 60 individuals (1.5%; n=18 new PE, n=42 persistent PE). Within the follow‐up period, 37 participants died and 93 participants reported a newly diagnosed malignancy. The presence of PE did not predict all‐cause death or the development of new malignancy.
Conclusions
Incidental PE was detected in about 3% of individuals, with the vast majority measuring
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Research and Epidemiology, Comprehensive Heart Failure Center University Hospital and University of Wurzburg Germany.
- Department of Medicine I, Division of Cardiology University Hospital of Wurzburg Germany.
- Institute of Clinical Epidemiology and Biometry University of Wurzburg Germany.
- Clinical Trial Center University Hospital and University of Wurzburg Germany.
- Institute of Medical Data Science University Hospital Wurzburg Germany.
ORCID-Profile: Floran Sahiti, Vladimir Cejka, Lena Schmidbauer, Fabian Kerwagen, Stefan Frantz, Peter U Heuschmann, Stefan Störk, Caroline Morbach
Zitieren
APA
Sahiti, F., Cejka, V., Schmidbauer, L., Albert, J., Kerwagen, F., Frantz, S., Gelbrich, G., Heuschmann, P. U., Störk, S., Morbach, C., & of the STAAB consortium * (2024). Prognostic Utility of Pericardial Effusion in the General Population: Findings From the STAAB Cohort Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.035549
Vancouver
Sahiti F, Cejka V, Schmidbauer L, Albert J, Kerwagen F, Frantz S, et al. Prognostic Utility of Pericardial Effusion in the General Population: Findings From the STAAB Cohort Study. Journal of the American Heart Association. 2024. doi:10.1161/jaha.124.035549
BibTeX
@article{Sahiti2024,
author = {Sahiti, Floran and Cejka, Vladimir and Schmidbauer, Lena and Albert, Judith and Kerwagen, Fabian and Frantz, Stefan and Gelbrich, Götz and Heuschmann, Peter U and Störk, Stefan and Morbach, Caroline and of the STAAB consortium *, of the STAAB consortium *},
title = {Prognostic Utility of Pericardial Effusion in the General Population: Findings From the STAAB Cohort Study},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.124.035549}
}
EUVIMED